Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation — Stella

Home/Severe COVID-19/Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation

View on ClinicalTrials.gov

Recruiting

Back to Severe COVID-19 trials

Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation

Trial locations(1 site)

France

Anesthesy department - Hôpital Pitié Salpêtrière, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~72 participants

Started

March 2022

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 74 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.